Human medicines European public assessment report (EPAR): Nexviadyme, avalglucosidase alfa, Date of authorisation: 24/06/2022, Revision: 6, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 23 January 2026 - 16:35

Human medicines European public assessment report (EPAR): Nexviadyme, avalglucosidase alfa, Date of authorisation: 24/06/2022, Revision: 6, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/nexviadyme

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters